Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Elicio Therapeutics Inc (NQ: ELTX ) 5.180 +0.190 (+3.81%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Elicio Therapeutics Inc < Previous 1 2 Next > Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday? June 28, 2024 Elicio Therapeutics announced promising preliminary data from the AMPLIFY-7P Phase 1a study of ELI-002 7P, showing extended median disease-free survival in patients with mKRAS-driven solid tumors. Via Benzinga Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today? June 28, 2024 Elicio Therapeutics stock is down on Friday after the company announced a proposed public offering for shares of ELTX this morning. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 28, 2024 Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower! Via InvestorPlace Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors June 10, 2024 Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors Via News Direct First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P February 01, 2024 --News Direct-- Via News Direct 12 Health Care Stocks Moving In Thursday's Intraday Session May 16, 2024 Via Benzinga ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q1 2024 May 15, 2024 ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry April 11, 2024 Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry Via News Direct 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga Unlocking the Power of Immunotherapy: Elicio Therapeutics’ (NASDAQ: ELTX) Novel AMP Platform April 05, 2024 --News Direct-- Via News Direct Topics Death Exposures Death ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023 April 02, 2024 ELTX stock results show that Elicio Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Benzinga's 2024 Virtual Healthcare: What's Next In Health? March 19, 2024 The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session March 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 07, 2024 Via Benzinga Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy February 06, 2024 --News Direct-- Via News Direct Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy February 05, 2024 A clinical-stage biotechnology company has published promising preclinical data in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR). Via Benzinga First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P January 31, 2024 A phase 2 trial by a clinical-stage biotechnology company is kicking into full gear. Via Benzinga Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002 January 30, 2024 --News Direct-- Via News Direct Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002 January 29, 2024 Colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) are the second and Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session January 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session January 19, 2024 Via Benzinga Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet January 12, 2024 A look at five stocks seeing increased attention from investors. Via Benzinga Unity Layoffs 2024: What to Know About the Latest U Job Cuts January 09, 2024 Unity layoffs are on the way as the video game software company reveals plans to cut 1,800 jobs to focus on its core business. Via InvestorPlace Topics Workforce Exposures Layoff Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today? January 09, 2024 Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance. Via InvestorPlace Why Is Grifols (GRFS) Stock Down 38% Today? January 09, 2024 Grifols stock is falling hard as investors sell GRFS shares after the company was hit with a short report from Gotham City Research. Via InvestorPlace < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
